About Index Trending news
Analyze
Top 50 Pricing
LYSOGENE

LYSOGENE

Work at LYSOGENE? Add yourself to this profile

LYSOGENE

Lysogene is a global leader in the basic research and clinical development of gene therapy for neurodegenerative disorders.

Elsewhere

Alexa global traffic share

Twitter followers

21 May 2014
$22,000,000
Venture capital (Series A)